Display options
Share it on

Oncol Lett. 2018 Mar;15(3):3329-3332. doi: 10.3892/ol.2017.7711. Epub 2017 Dec 28.

[No title available]

Oncology letters

Davide Bondavalli, Francesca Malvestiti, Valeria Pensotti, Irene Feroce, Bernardo Bonanni

Affiliations

  1. Division of Cancer Prevention and Genetics, European Oncologic Institute, I-20141 Milan, Italy.
  2. Research and Development, Cytogenetics and Molecular Biology, TOMA Advanced Biomedical Assays S.p.A., I-21052 Busto Arsizio, Italy.
  3. Istituto FIRC di Oncologia Molecolare (IFOM), I-20139 Milan, Italy.
  4. Cogentech, Cancer Genetic Test Laboratory, I-20139 Milan, Italy.

PMID: 29435075 PMCID: PMC5778837 DOI: 10.3892/ol.2017.7711

Abstract

The present case report discusses a woman affected by chronic lymphatic leukemia and breast cancer with a familial history of breast cancer; suspected to be hereditary breast and ovarian cancer (HBOC) syndrome. The patient underwent

Keywords: Fanconi anemia; diepoxybutane test; hereditary breast and ovarian cancer syndrome; homozygous BRCA1; p.Arg1028Cys

References

  1. Pediatrics. 1981 Jan;67(1):128-35 - PubMed
  2. Br J Haematol. 2017 Jul;178(1):32-47 - PubMed
  3. Mutat Res. 2009 Jul 31;668(1-2):4-10 - PubMed
  4. Cancer Discov. 2015 Feb;5(2):135-42 - PubMed
  5. Mamm Genome. 2006 Mar;17(3):257-70 - PubMed
  6. J Clin Oncol. 2007 Apr 10;25(11):1329-33 - PubMed
  7. Nature. 1995 Jun 15;375(6532):541-2 - PubMed
  8. Exp Hematol. 1993 Jun;21(6):731-3 - PubMed
  9. Semin Oncol. 2011 Aug;38(4):469-80 - PubMed
  10. J Community Genet. 2015 Oct;6(4):351-9 - PubMed
  11. Cancer Discov. 2013 Apr;3(4):399-405 - PubMed

Publication Types